BioAegis Therapeutics
2011
FOUNDED
PRIVATE
STATUS
11-20
EMPLOYEES
Series B
LATEST DEAL TYPE
$4.1M
LATEST DEAL AMOUNT
1
INVESTORS
Description
Developer of drugs designed to address the challenges of inflammation and infectious diseases. The company's drugs restore plasma gelsolin, a key component of innate immunity, provides an immunotherapeutic approach to fight with pathogens, enabling patients to begin treatment more quickly and result in a higher likelihood of a successful treatment.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
- 675 US Highway One
- Garden State Parkway, NJ 07960
- United States
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore BioAegis Therapeutics’s full profile, request a free trial.
BioAegis Therapeutics Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series B) | 01-Aug-2018 | $4.1M | 000.00 | 000.00 | Completed | Clinical Trials - General |
| 4. Grant | 09-Jul-2016 | 00.00 | 000.00 | Completed | Clinical Trials - Phase 2 | |
| 3. Angel (individual) | 11-Mar-2016 | 00.00 | 000.00 | 0000 | Completed | Startup |
| 2. Angel (individual) | 01-Jan-2015 | $8.04M | $11M | 0000 | Completed | Startup |
| 1. Angel (individual) | 08-Feb-2013 | $3M | $3M | Completed | Startup |
BioAegis Therapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| National Institute Of Allergy and Infectious Diseases | Government | 000 0000 | 000000 0 |
BioAegis Therapeutics Executive Team (14)
1 Former Executive
You’re viewing 5 of 14 executives. Get the full list »BioAegis Therapeutics Board Members (3)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Susan Levinson Ph.D | Self | Co-Founder, Board Member & Chief Executive Officer | 000 0000 | |
| Thomas Stossel MD | BioAegis Therapeutics | Co-Founder, Board Member & Scientific Advisor | 000 0000 | |
| Valerie Ceva | Self | Co-Founder, Board Member & Chief Operating Officer | 000 0000 |